Type 1 diabetes (T1D) is characterized by immune-mediated destruction of pancreatic β cells, leading to insulin deficiency and hyperglycemia, necessitating lifelong exogenous insulin therapy. This evidence concerns the gene INS and type 1 diabetes mellitus.